Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew Zirwas

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Dermatitis : Contact, Atopic, Occupational, Drug|March 17, 2022
Contact Allergy Cross-reactions and Thresholds: A ReviewAndrew Scheman, Jenna L Ruggiero, Lillian Kerchinsky, et al.
Dermatology and Therapy|July 18, 2025
The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.
Journal of the American Academy of Dermatology|November 14, 2025
Combined impact of lesion and itch severity on initiation of biologic treatment in patients with moderate or severe atopic dermatitis from specialty dermatology facilities in the United StatesGil Yosipovitch, Matthew Zirwas, Lawrence Rasouliyan, et al.
The Journal of Dermatological Treatment|March 11, 2025
Patient and healthcare provider perspectives on treatment patterns and patient satisfaction of seborrheic dermatitis in the United StatesRaj Chovatiya, Christy H Chang, Lakshi Aldredge, et al.
Dermatology and Therapy|October 28, 2024
Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National SurveyMeredith T Polaskey, Lakshi Aldredge, Candrice Heath, et al.
Advances in Therapy|September 30, 2024
Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United StatesRaj Chovatiya, Meredith T Polaskey, Lakshi Aldredge, et al.
Journal of the American Academy of Dermatology|September 1, 2025
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind StudyMatthew Zirwas, Joseph F Fowler, Athanasios Tsianakas, et al.
Dermatology and Therapy|December 20, 2023
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque PsoriasisLeon Kircik, Matthew Zirwas, Shawn G Kwatra, et al.
The Journal of Clinical and Aesthetic Dermatology|November 24, 2016
A Retrospective Analysis Comparing the New Standardized Letter of Recommendation in Dermatology with the Classic Narrative Letter of RecommendationJessica A Kaffenberger, Joy Mosser, Grace Lee, et al.
Clinical Nephrology|January 17, 2013
Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfallAnjali A Satoskar, Matthew Molenda, Patrice Scipio, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Dermatitis : Contact, Atopic, Occupational, Drug|March 17, 2022
Contact Allergy Cross-reactions and Thresholds: A ReviewAndrew Scheman, Jenna L Ruggiero, Lillian Kerchinsky, et al.
Dermatology and Therapy|July 18, 2025
The Tralokinumab Pre-Filled Pen Improved Atopic Dermatitis Signs and Symptoms and Was Well Tolerated in Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis: A 16-Week, Open-Label, Single-Arm Phase 3 Study (INJECZTRA)Jennifer Soung, Vivian Laquer, Matthew Zirwas, et al.
Journal of the American Academy of Dermatology|November 14, 2025
Combined impact of lesion and itch severity on initiation of biologic treatment in patients with moderate or severe atopic dermatitis from specialty dermatology facilities in the United StatesGil Yosipovitch, Matthew Zirwas, Lawrence Rasouliyan, et al.
The Journal of Dermatological Treatment|March 11, 2025
Patient and healthcare provider perspectives on treatment patterns and patient satisfaction of seborrheic dermatitis in the United StatesRaj Chovatiya, Christy H Chang, Lakshi Aldredge, et al.
Dermatology and Therapy|October 28, 2024
Patient and Healthcare Provider Perspectives on Disease Burden of Seborrheic Dermatitis in the United States: Results from a National SurveyMeredith T Polaskey, Lakshi Aldredge, Candrice Heath, et al.
Advances in Therapy|September 30, 2024
Patient and Healthcare Provider Perspectives on the Pathway to Diagnosis of Seborrheic Dermatitis in the United StatesRaj Chovatiya, Meredith T Polaskey, Lakshi Aldredge, et al.
Journal of the American Academy of Dermatology|September 1, 2025
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Moderate to Severe Chronic Hand Eczema: Results From a 16-Week, Multicenter, Randomized, Double-Blind StudyMatthew Zirwas, Joseph F Fowler, Athanasios Tsianakas, et al.
Dermatology and Therapy|December 20, 2023
Rapid Improvements in Itch with Tapinarof Cream 1% Once Daily in Two Phase 3 Trials in Adults with Mild to Severe Plaque PsoriasisLeon Kircik, Matthew Zirwas, Shawn G Kwatra, et al.
The Journal of Clinical and Aesthetic Dermatology|November 24, 2016
A Retrospective Analysis Comparing the New Standardized Letter of Recommendation in Dermatology with the Classic Narrative Letter of RecommendationJessica A Kaffenberger, Joy Mosser, Grace Lee, et al.
Clinical Nephrology|January 17, 2013
Henoch-Schönlein purpura-like presentation in IgA-dominant Staphylococcus infection - associated glomerulonephritis - a diagnostic pitfallAnjali A Satoskar, Matthew Molenda, Patrice Scipio, et al.
Pageof 8